REVIEW OF METHODOLOGICAL QUALITY OF BUDGET IMPACT ANALYSES FOR ORPHAN DRUGS

被引：0
|
作者：
Abdallah, K. [1 ]
Kiani, P. [1 ]
Huys, I [1 ]
Claes, K. [1 ]
Simoens, S. [1 ]
机构：
[1] Katholieke Univ Leuven, B-3000 Leuven, Vbr, Belgium
来源：
VALUE IN HEALTH | 2019年 / 22卷
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PNS53
引用
收藏
页码：S771 / S771
页数：1
相关论文
共 50 条
  • [41] Pricing and reimbursement policy for new orphan drugs in South Korea: focused on patient accessibility and budget impact
    Lee, Jong Hyuk
    Yoo, Seung-Lai
    EXPERT OPINION ON ORPHAN DRUGS, 2022, 10 (01): : 23 - 28
  • [42] Market Exclusivity for Drugs with Multiple Orphan Approvals (1983-2017) and Associated Budget Impact in the US
    Padula, William V.
    Parasrampuria, Sonal
    Socal, Mariana P.
    Conti, Rena M.
    Anderson, Gerard F.
    PHARMACOECONOMICS, 2020, 38 (10) : 1115 - 1121
  • [43] Orphan Drugs and Their Impact on Pharmaceutical Development
    Attwood, Misty M.
    Rask-Andersen, Mathias
    Schioth, Helgi B.
    TRENDS IN PHARMACOLOGICAL SCIENCES, 2018, 39 (06) : 525 - 535
  • [44] THE RISE OF BUDGET IMPACT ANALYSES
    Wong, G. K.
    Hamer, N.
    Wilson, T.
    Costello, S.
    VALUE IN HEALTH, 2012, 15 (04) : A161 - A161
  • [45] The quality of economic evaluations of ultra-orphan drugs in Europe - a systematic review
    Schuller, Y.
    Hollak, C. E. M.
    Biegstraaten, M.
    ORPHANET JOURNAL OF RARE DISEASES, 2015, 10
  • [46] The quality of economic evaluations of ultra-orphan drugs in Europe – a systematic review
    Y. Schuller
    C. E. M. Hollak
    M. Biegstraaten
    Orphanet Journal of Rare Diseases, 10
  • [47] Orphan drugs: Review of the EU program
    Del Signore, S.
    EPILEPSIA, 2006, 47 : 238 - 238
  • [48] Budget impact analyses for treatment of heart failure. A systematic review
    Teimourizad, Abedin
    Jafari, Abdosaleh
    Esmaeilzadeh, Firooz
    HEART FAILURE REVIEWS, 2024, 29 (04) : 785 - 797
  • [49] METHODOLOGICAL QUALITY OF META-ANALYSES ON COGNITION IN SCHIZOPHRENIA: A SYSTEMATIC REVIEW
    Cellard, Caroline
    Pothier, William
    East-Richard, Caroline
    Turcotte, Melissa
    Thibaudeau, Elisabeth
    Roy, Marc-Andre
    SCHIZOPHRENIA BULLETIN, 2017, 43 : S222 - S222
  • [50] Comment on "Market Exclusivity for Drugs with Multiple Orphan Approvals (1983-2017) and Associated Budget Impact in the US"
    Manning, Richard
    PHARMACOECONOMICS, 2020, 38 (12) : 1373 - 1374
12345